nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—CYP1A2—Pentoxifylline—systemic scleroderma	0.104	0.389	CbGbCtD
Dexmedetomidine—CYP1A2—Leflunomide—systemic scleroderma	0.0992	0.371	CbGbCtD
Dexmedetomidine—CYP2D6—Captopril—systemic scleroderma	0.0641	0.24	CbGbCtD
Dexmedetomidine—Tachycardia—Captopril—systemic scleroderma	0.00109	0.00148	CcSEcCtD
Dexmedetomidine—Pain—Mometasone—systemic scleroderma	0.00108	0.00148	CcSEcCtD
Dexmedetomidine—Mental disorder—Mycophenolic acid—systemic scleroderma	0.00108	0.00147	CcSEcCtD
Dexmedetomidine—Malnutrition—Mycophenolic acid—systemic scleroderma	0.00107	0.00146	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00146	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00145	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00145	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00144	CcSEcCtD
Dexmedetomidine—Hypotension—Captopril—systemic scleroderma	0.00104	0.00142	CcSEcCtD
Dexmedetomidine—Anaemia—Leflunomide—systemic scleroderma	0.00104	0.00142	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00104	0.00141	CcSEcCtD
Dexmedetomidine—Angiopathy—Lisinopril—systemic scleroderma	0.00101	0.00137	CcSEcCtD
Dexmedetomidine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.001	0.00137	CcSEcCtD
Dexmedetomidine—Abdominal pain—Mometasone—systemic scleroderma	0.001	0.00137	CcSEcCtD
Dexmedetomidine—Body temperature increased—Mometasone—systemic scleroderma	0.001	0.00137	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Lisinopril—systemic scleroderma	0.000999	0.00136	CcSEcCtD
Dexmedetomidine—Chills—Lisinopril—systemic scleroderma	0.000995	0.00136	CcSEcCtD
Dexmedetomidine—Dyspnoea—Captopril—systemic scleroderma	0.000992	0.00135	CcSEcCtD
Dexmedetomidine—Arrhythmia—Lisinopril—systemic scleroderma	0.00099	0.00135	CcSEcCtD
Dexmedetomidine—Anaemia—Mycophenolic acid—systemic scleroderma	0.00099	0.00135	CcSEcCtD
Dexmedetomidine—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.000989	0.00135	CcSEcCtD
Dexmedetomidine—Somnolence—Captopril—systemic scleroderma	0.000989	0.00135	CcSEcCtD
Dexmedetomidine—Agitation—Mycophenolic acid—systemic scleroderma	0.000985	0.00134	CcSEcCtD
Dexmedetomidine—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000976	0.00133	CcSEcCtD
Dexmedetomidine—Pulmonary oedema—Methotrexate—systemic scleroderma	0.000975	0.00133	CcSEcCtD
Dexmedetomidine—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000971	0.00133	CcSEcCtD
Dexmedetomidine—Mental disorder—Lisinopril—systemic scleroderma	0.000971	0.00133	CcSEcCtD
Dexmedetomidine—Dizziness—Pentoxifylline—systemic scleroderma	0.00097	0.00132	CcSEcCtD
Dexmedetomidine—Hypertension—Leflunomide—systemic scleroderma	0.00097	0.00132	CcSEcCtD
Dexmedetomidine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000967	0.00132	CcSEcCtD
Dexmedetomidine—Malnutrition—Lisinopril—systemic scleroderma	0.000965	0.00132	CcSEcCtD
Dexmedetomidine—Infection—Azathioprine—systemic scleroderma	0.000964	0.00132	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.000957	0.00131	CcSEcCtD
Dexmedetomidine—Anxiety—Leflunomide—systemic scleroderma	0.000953	0.0013	CcSEcCtD
Dexmedetomidine—Constipation—Captopril—systemic scleroderma	0.000951	0.0013	CcSEcCtD
Dexmedetomidine—Sepsis—Methotrexate—systemic scleroderma	0.000951	0.0013	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00095	0.0013	CcSEcCtD
Dexmedetomidine—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.000936	0.00128	CcSEcCtD
Dexmedetomidine—Dry mouth—Leflunomide—systemic scleroderma	0.000935	0.00128	CcSEcCtD
Dexmedetomidine—Vomiting—Pentoxifylline—systemic scleroderma	0.000933	0.00127	CcSEcCtD
Dexmedetomidine—Convulsion—Mycophenolic acid—systemic scleroderma	0.000928	0.00127	CcSEcCtD
Dexmedetomidine—Rash—Pentoxifylline—systemic scleroderma	0.000925	0.00126	CcSEcCtD
Dexmedetomidine—Hypertension—Mycophenolic acid—systemic scleroderma	0.000925	0.00126	CcSEcCtD
Dexmedetomidine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000924	0.00126	CcSEcCtD
Dexmedetomidine—Headache—Pentoxifylline—systemic scleroderma	0.000919	0.00125	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Captopril—systemic scleroderma	0.000917	0.00125	CcSEcCtD
Dexmedetomidine—Infection—Leflunomide—systemic scleroderma	0.000911	0.00124	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000909	0.00124	CcSEcCtD
Dexmedetomidine—Anxiety—Mycophenolic acid—systemic scleroderma	0.000909	0.00124	CcSEcCtD
Dexmedetomidine—Hypotension—Azathioprine—systemic scleroderma	0.000907	0.00124	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Prednisone—systemic scleroderma	0.000905	0.00124	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000902	0.00123	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000898	0.00123	CcSEcCtD
Dexmedetomidine—Tachycardia—Leflunomide—systemic scleroderma	0.000895	0.00122	CcSEcCtD
Dexmedetomidine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000892	0.00122	CcSEcCtD
Dexmedetomidine—Anaemia—Lisinopril—systemic scleroderma	0.000892	0.00122	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000886	0.00121	CcSEcCtD
Dexmedetomidine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000882	0.0012	CcSEcCtD
Dexmedetomidine—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000881	0.0012	CcSEcCtD
Dexmedetomidine—Body temperature increased—Captopril—systemic scleroderma	0.000879	0.0012	CcSEcCtD
Dexmedetomidine—Abdominal pain—Captopril—systemic scleroderma	0.000879	0.0012	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000875	0.00119	CcSEcCtD
Dexmedetomidine—Nausea—Pentoxifylline—systemic scleroderma	0.000872	0.00119	CcSEcCtD
Dexmedetomidine—Chills—Mycophenolate mofetil—systemic scleroderma	0.000872	0.00119	CcSEcCtD
Dexmedetomidine—Infection—Mycophenolic acid—systemic scleroderma	0.000869	0.00119	CcSEcCtD
Dexmedetomidine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000868	0.00118	CcSEcCtD
Dexmedetomidine—Diarrhoea—Mometasone—systemic scleroderma	0.000866	0.00118	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Prednisone—systemic scleroderma	0.000866	0.00118	CcSEcCtD
Dexmedetomidine—Renal failure acute—Methotrexate—systemic scleroderma	0.000862	0.00118	CcSEcCtD
Dexmedetomidine—Hypotension—Leflunomide—systemic scleroderma	0.000857	0.00117	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000856	0.00117	CcSEcCtD
Dexmedetomidine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000853	0.00116	CcSEcCtD
Dexmedetomidine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000851	0.00116	CcSEcCtD
Dexmedetomidine—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000846	0.00115	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000845	0.00115	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000839	0.00115	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000838	0.00114	CcSEcCtD
Dexmedetomidine—Abdominal distension—Prednisone—systemic scleroderma	0.000828	0.00113	CcSEcCtD
Dexmedetomidine—Anxiety—Lisinopril—systemic scleroderma	0.000819	0.00112	CcSEcCtD
Dexmedetomidine—Dyspnoea—Leflunomide—systemic scleroderma	0.000817	0.00112	CcSEcCtD
Dexmedetomidine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000817	0.00112	CcSEcCtD
Dexmedetomidine—Vomiting—Mometasone—systemic scleroderma	0.000805	0.0011	CcSEcCtD
Dexmedetomidine—Dry mouth—Lisinopril—systemic scleroderma	0.000804	0.0011	CcSEcCtD
Dexmedetomidine—Sweating increased—Prednisone—systemic scleroderma	0.000801	0.00109	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Azathioprine—systemic scleroderma	0.0008	0.00109	CcSEcCtD
Dexmedetomidine—Rash—Mometasone—systemic scleroderma	0.000798	0.00109	CcSEcCtD
Dexmedetomidine—Dermatitis—Mometasone—systemic scleroderma	0.000798	0.00109	CcSEcCtD
Dexmedetomidine—Confusional state—Lisinopril—systemic scleroderma	0.000794	0.00108	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000794	0.00108	CcSEcCtD
Dexmedetomidine—Headache—Mometasone—systemic scleroderma	0.000793	0.00108	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000791	0.00108	CcSEcCtD
Dexmedetomidine—Constipation—Leflunomide—systemic scleroderma	0.000784	0.00107	CcSEcCtD
Dexmedetomidine—Pain—Leflunomide—systemic scleroderma	0.000784	0.00107	CcSEcCtD
Dexmedetomidine—Infection—Lisinopril—systemic scleroderma	0.000783	0.00107	CcSEcCtD
Dexmedetomidine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000782	0.00107	CcSEcCtD
Dexmedetomidine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00078	0.00106	CcSEcCtD
Dexmedetomidine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000777	0.00106	CcSEcCtD
Dexmedetomidine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000777	0.00106	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000771	0.00105	CcSEcCtD
Dexmedetomidine—Tachycardia—Lisinopril—systemic scleroderma	0.000769	0.00105	CcSEcCtD
Dexmedetomidine—Abdominal pain—Azathioprine—systemic scleroderma	0.000767	0.00105	CcSEcCtD
Dexmedetomidine—Body temperature increased—Azathioprine—systemic scleroderma	0.000767	0.00105	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000761	0.00104	CcSEcCtD
Dexmedetomidine—Diarrhoea—Captopril—systemic scleroderma	0.000761	0.00104	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000755	0.00103	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000755	0.00103	CcSEcCtD
Dexmedetomidine—Nausea—Mometasone—systemic scleroderma	0.000752	0.00103	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00075	0.00102	CcSEcCtD
Dexmedetomidine—Pain—Mycophenolic acid—systemic scleroderma	0.000748	0.00102	CcSEcCtD
Dexmedetomidine—Constipation—Mycophenolic acid—systemic scleroderma	0.000748	0.00102	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Prednisone—systemic scleroderma	0.000742	0.00101	CcSEcCtD
Dexmedetomidine—Hypotension—Lisinopril—systemic scleroderma	0.000736	0.001	CcSEcCtD
Dexmedetomidine—Dizziness—Captopril—systemic scleroderma	0.000735	0.001	CcSEcCtD
Dexmedetomidine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000733	0.001	CcSEcCtD
Dexmedetomidine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00073	0.000996	CcSEcCtD
Dexmedetomidine—Abdominal pain—Leflunomide—systemic scleroderma	0.000725	0.000989	CcSEcCtD
Dexmedetomidine—Body temperature increased—Leflunomide—systemic scleroderma	0.000725	0.000989	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000723	0.000987	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000721	0.000984	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000719	0.000981	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Prednisone—systemic scleroderma	0.000719	0.000981	CcSEcCtD
Dexmedetomidine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000717	0.000979	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000715	0.000976	CcSEcCtD
Dexmedetomidine—Vomiting—Captopril—systemic scleroderma	0.000707	0.000965	CcSEcCtD
Dexmedetomidine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000704	0.000961	CcSEcCtD
Dexmedetomidine—Dyspnoea—Lisinopril—systemic scleroderma	0.000702	0.000958	CcSEcCtD
Dexmedetomidine—Rash—Captopril—systemic scleroderma	0.000701	0.000957	CcSEcCtD
Dexmedetomidine—Dermatitis—Captopril—systemic scleroderma	0.000701	0.000956	CcSEcCtD
Dexmedetomidine—Somnolence—Lisinopril—systemic scleroderma	0.0007	0.000956	CcSEcCtD
Dexmedetomidine—Headache—Captopril—systemic scleroderma	0.000697	0.000951	CcSEcCtD
Dexmedetomidine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000696	0.00095	CcSEcCtD
Dexmedetomidine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000691	0.000944	CcSEcCtD
Dexmedetomidine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000691	0.000944	CcSEcCtD
Dexmedetomidine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000686	0.000936	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00068	0.000928	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000676	0.000922	CcSEcCtD
Dexmedetomidine—Constipation—Lisinopril—systemic scleroderma	0.000674	0.000919	CcSEcCtD
Dexmedetomidine—Pain—Lisinopril—systemic scleroderma	0.000674	0.000919	CcSEcCtD
Dexmedetomidine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000674	0.000919	CcSEcCtD
Dexmedetomidine—Bradycardia—Prednisone—systemic scleroderma	0.00067	0.000915	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000667	0.000911	CcSEcCtD
Dexmedetomidine—Diarrhoea—Azathioprine—systemic scleroderma	0.000664	0.000906	CcSEcCtD
Dexmedetomidine—Haemoglobin—Prednisone—systemic scleroderma	0.000662	0.000903	CcSEcCtD
Dexmedetomidine—Nausea—Captopril—systemic scleroderma	0.000661	0.000902	CcSEcCtD
Dexmedetomidine—Haemorrhage—Prednisone—systemic scleroderma	0.000658	0.000899	CcSEcCtD
Dexmedetomidine—Hallucination—Prednisone—systemic scleroderma	0.000655	0.000894	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000649	0.000886	CcSEcCtD
Dexmedetomidine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000645	0.00088	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000644	0.000879	CcSEcCtD
Dexmedetomidine—Dizziness—Azathioprine—systemic scleroderma	0.000642	0.000876	CcSEcCtD
Dexmedetomidine—Diarrhoea—Leflunomide—systemic scleroderma	0.000627	0.000856	CcSEcCtD
Dexmedetomidine—Abdominal pain—Lisinopril—systemic scleroderma	0.000623	0.00085	CcSEcCtD
Dexmedetomidine—Body temperature increased—Lisinopril—systemic scleroderma	0.000623	0.00085	CcSEcCtD
Dexmedetomidine—Vomiting—Azathioprine—systemic scleroderma	0.000617	0.000842	CcSEcCtD
Dexmedetomidine—Pneumonia—Methotrexate—systemic scleroderma	0.000617	0.000842	CcSEcCtD
Dexmedetomidine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000615	0.00084	CcSEcCtD
Dexmedetomidine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000614	0.000837	CcSEcCtD
Dexmedetomidine—Rash—Azathioprine—systemic scleroderma	0.000612	0.000835	CcSEcCtD
Dexmedetomidine—Dermatitis—Azathioprine—systemic scleroderma	0.000611	0.000835	CcSEcCtD
Dexmedetomidine—Headache—Azathioprine—systemic scleroderma	0.000608	0.00083	CcSEcCtD
Dexmedetomidine—Dizziness—Leflunomide—systemic scleroderma	0.000606	0.000827	CcSEcCtD
Dexmedetomidine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000598	0.000817	CcSEcCtD
Dexmedetomidine—Angiopathy—Prednisone—systemic scleroderma	0.000597	0.000815	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000596	0.000813	CcSEcCtD
Dexmedetomidine—Pain—Mycophenolate mofetil—systemic scleroderma	0.00059	0.000806	CcSEcCtD
Dexmedetomidine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00059	0.000806	CcSEcCtD
Dexmedetomidine—Arrhythmia—Prednisone—systemic scleroderma	0.000588	0.000803	CcSEcCtD
Dexmedetomidine—Vomiting—Leflunomide—systemic scleroderma	0.000583	0.000796	CcSEcCtD
Dexmedetomidine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000578	0.000789	CcSEcCtD
Dexmedetomidine—Rash—Leflunomide—systemic scleroderma	0.000578	0.000789	CcSEcCtD
Dexmedetomidine—Dermatitis—Leflunomide—systemic scleroderma	0.000577	0.000788	CcSEcCtD
Dexmedetomidine—Mental disorder—Prednisone—systemic scleroderma	0.000577	0.000787	CcSEcCtD
Dexmedetomidine—Nausea—Azathioprine—systemic scleroderma	0.000577	0.000787	CcSEcCtD
Dexmedetomidine—Headache—Leflunomide—systemic scleroderma	0.000574	0.000784	CcSEcCtD
Dexmedetomidine—Malnutrition—Prednisone—systemic scleroderma	0.000573	0.000782	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000569	0.000776	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000564	0.00077	CcSEcCtD
Dexmedetomidine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000556	0.000759	CcSEcCtD
Dexmedetomidine—Haemoglobin—Methotrexate—systemic scleroderma	0.000553	0.000755	CcSEcCtD
Dexmedetomidine—Rash—Mycophenolic acid—systemic scleroderma	0.000551	0.000753	CcSEcCtD
Dexmedetomidine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000551	0.000752	CcSEcCtD
Dexmedetomidine—Haemorrhage—Methotrexate—systemic scleroderma	0.00055	0.000751	CcSEcCtD
Dexmedetomidine—Headache—Mycophenolic acid—systemic scleroderma	0.000548	0.000748	CcSEcCtD
Dexmedetomidine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000546	0.000745	CcSEcCtD
Dexmedetomidine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000546	0.000745	CcSEcCtD
Dexmedetomidine—Nausea—Leflunomide—systemic scleroderma	0.000544	0.000743	CcSEcCtD
Dexmedetomidine—Diarrhoea—Lisinopril—systemic scleroderma	0.000539	0.000736	CcSEcCtD
Dexmedetomidine—Visual impairment—Methotrexate—systemic scleroderma	0.00053	0.000724	CcSEcCtD
Dexmedetomidine—Anaemia—Prednisone—systemic scleroderma	0.00053	0.000723	CcSEcCtD
Dexmedetomidine—Agitation—Prednisone—systemic scleroderma	0.000527	0.000719	CcSEcCtD
Dexmedetomidine—Dizziness—Lisinopril—systemic scleroderma	0.000521	0.000711	CcSEcCtD
Dexmedetomidine—Nausea—Mycophenolic acid—systemic scleroderma	0.000519	0.000709	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000511	0.000697	CcSEcCtD
Dexmedetomidine—Vomiting—Lisinopril—systemic scleroderma	0.000501	0.000684	CcSEcCtD
Dexmedetomidine—Angiopathy—Methotrexate—systemic scleroderma	0.000499	0.000681	CcSEcCtD
Dexmedetomidine—Rash—Lisinopril—systemic scleroderma	0.000497	0.000678	CcSEcCtD
Dexmedetomidine—Convulsion—Prednisone—systemic scleroderma	0.000497	0.000678	CcSEcCtD
Dexmedetomidine—Dermatitis—Lisinopril—systemic scleroderma	0.000496	0.000677	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000496	0.000677	CcSEcCtD
Dexmedetomidine—Hypertension—Prednisone—systemic scleroderma	0.000495	0.000675	CcSEcCtD
Dexmedetomidine—Chills—Methotrexate—systemic scleroderma	0.000494	0.000674	CcSEcCtD
Dexmedetomidine—Headache—Lisinopril—systemic scleroderma	0.000493	0.000674	CcSEcCtD
Dexmedetomidine—Anxiety—Prednisone—systemic scleroderma	0.000486	0.000664	CcSEcCtD
Dexmedetomidine—Mental disorder—Methotrexate—systemic scleroderma	0.000482	0.000658	CcSEcCtD
Dexmedetomidine—Malnutrition—Methotrexate—systemic scleroderma	0.000479	0.000654	CcSEcCtD
Dexmedetomidine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000472	0.000644	CcSEcCtD
Dexmedetomidine—Nausea—Lisinopril—systemic scleroderma	0.000468	0.000639	CcSEcCtD
Dexmedetomidine—Infection—Prednisone—systemic scleroderma	0.000465	0.000634	CcSEcCtD
Dexmedetomidine—Tachycardia—Prednisone—systemic scleroderma	0.000457	0.000623	CcSEcCtD
Dexmedetomidine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000456	0.000623	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000452	0.000617	CcSEcCtD
Dexmedetomidine—Anaemia—Methotrexate—systemic scleroderma	0.000443	0.000604	CcSEcCtD
Dexmedetomidine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000439	0.000599	CcSEcCtD
Dexmedetomidine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000435	0.000594	CcSEcCtD
Dexmedetomidine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000435	0.000593	CcSEcCtD
Dexmedetomidine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000432	0.00059	CcSEcCtD
Dexmedetomidine—Convulsion—Methotrexate—systemic scleroderma	0.000415	0.000567	CcSEcCtD
Dexmedetomidine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00041	0.00056	CcSEcCtD
Dexmedetomidine—Constipation—Prednisone—systemic scleroderma	0.0004	0.000546	CcSEcCtD
Dexmedetomidine—Confusional state—Methotrexate—systemic scleroderma	0.000394	0.000538	CcSEcCtD
Dexmedetomidine—Infection—Methotrexate—systemic scleroderma	0.000388	0.00053	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Prednisone—systemic scleroderma	0.000385	0.000526	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000383	0.000522	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000383	0.000522	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000378	0.000516	CcSEcCtD
Dexmedetomidine—Body temperature increased—Prednisone—systemic scleroderma	0.00037	0.000505	CcSEcCtD
Dexmedetomidine—Abdominal pain—Prednisone—systemic scleroderma	0.00037	0.000505	CcSEcCtD
Dexmedetomidine—Hypotension—Methotrexate—systemic scleroderma	0.000365	0.000499	CcSEcCtD
Dexmedetomidine—Dyspnoea—Methotrexate—systemic scleroderma	0.000349	0.000476	CcSEcCtD
Dexmedetomidine—Somnolence—Methotrexate—systemic scleroderma	0.000348	0.000474	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000338	0.000461	CcSEcCtD
Dexmedetomidine—Pain—Methotrexate—systemic scleroderma	0.000334	0.000456	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000322	0.00044	CcSEcCtD
Dexmedetomidine—Diarrhoea—Prednisone—systemic scleroderma	0.00032	0.000437	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00032	0.000436	CcSEcCtD
Dexmedetomidine—Dizziness—Prednisone—systemic scleroderma	0.000309	0.000422	CcSEcCtD
Dexmedetomidine—Body temperature increased—Methotrexate—systemic scleroderma	0.000309	0.000422	CcSEcCtD
Dexmedetomidine—Abdominal pain—Methotrexate—systemic scleroderma	0.000309	0.000422	CcSEcCtD
Dexmedetomidine—Vomiting—Prednisone—systemic scleroderma	0.000297	0.000406	CcSEcCtD
Dexmedetomidine—Rash—Prednisone—systemic scleroderma	0.000295	0.000403	CcSEcCtD
Dexmedetomidine—Dermatitis—Prednisone—systemic scleroderma	0.000295	0.000402	CcSEcCtD
Dexmedetomidine—Headache—Prednisone—systemic scleroderma	0.000293	0.0004	CcSEcCtD
Dexmedetomidine—Nausea—Prednisone—systemic scleroderma	0.000278	0.000379	CcSEcCtD
Dexmedetomidine—Diarrhoea—Methotrexate—systemic scleroderma	0.000267	0.000365	CcSEcCtD
Dexmedetomidine—Dizziness—Methotrexate—systemic scleroderma	0.000259	0.000353	CcSEcCtD
Dexmedetomidine—Vomiting—Methotrexate—systemic scleroderma	0.000249	0.000339	CcSEcCtD
Dexmedetomidine—Rash—Methotrexate—systemic scleroderma	0.000247	0.000336	CcSEcCtD
Dexmedetomidine—Dermatitis—Methotrexate—systemic scleroderma	0.000246	0.000336	CcSEcCtD
Dexmedetomidine—Headache—Methotrexate—systemic scleroderma	0.000245	0.000334	CcSEcCtD
Dexmedetomidine—Nausea—Methotrexate—systemic scleroderma	0.000232	0.000317	CcSEcCtD
